Metropolitan Research   Report issue

For profit Phase 2
Founded: Fairfax VA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2008
NCT00637923
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3